Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Cohort Study of Polymyxin B Pharmacokinetics and Acute Kidney Injury Risk in Critically Ill Patients
ChiCTR2600122537Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Apr 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in Infection and Gram-negative bacterial infection, sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Serum polymyxin B concentration. Started Apr 2026; status: completed.
02
Drugs
polymyxin B
03
Conditions
InfectionGram-negative bacterial infection
Beyond the preview
Go deeper on ChiCTR2600122537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122537.